27/05/2025
https://npmoleculeoncology.com/product/laronib-100-mg-HIoSmh
Laronib 100 mg is a targeted cancer therapy developed by Everest Pharmaceuticals Ltd. in Bangladesh. It contains Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor,